SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...
Tech giants are rushing to build data centers in Indiana. Communities are pushing back — and winning
Tech giants are rushing to build data centers in the Midwest. Some Indiana communities are disrupting their plans.
Singer Sophia James went viral for creating exclusive groups on TikTok as a “science experiment” to promote her music. She ...
The use of CGM has been growing among people without diabetes, including those with prediabetes, particularly with the availability of the over-the-counter (OTC) devices Dexcom’s Stelo and Abbott’s ...
A novel once-daily oral PCSK9 inhibitor lowered LDL by up to 60% at 24 weeks in patients with heart disease or at high risk ...
BoC cut its key interest rate by 25bps to 2.25%. The bank has also signaled it will likely pause any further rate cuts for ...
13don MSN
Retirees and students in Florida are seeking to defend 2020 census results against a GOP challenge
Two Florida college students and an advocacy group for retirees are asking a federal judge to let them intervene in a lawsuit ...
A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight ...
The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with ...
Are you a part of 'Group 7'? If you don't know what that means at all, here's what to know and how TikTok differs from '6-7' meme ...
Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...
MedPage Today on MSN
Spondyloarthritis Treatment in Canada Falls Well Short of Ideal
Multiple TNF inhibitors, as well as interleukin-17 blockers such as secukinumab (Cosentyx) and Janus kinase (JAK) inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results